Oxford-AstraZeneca vaccine may pose fewer distribution challenges

That would be an advantage particularly for getting a COVID-19 vaccine to developing countries.
An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on Nov. 17, 2020.
Justin Tallis/AFP via Getty Images